Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Taddei

Showing results (101-110 of 291) with videos related to

Pageof 30
Sort By:
Vascular Pharmacology|October 13, 2015
Saxagliptin prevents vascular remodeling and oxidative stress in db/db mice. Role of endothelial nitric oxide synthase uncoupling and cyclooxygenaseAnna Solini, Chiara Rossi, Emiliano Duranti, et al.
Current Pharmaceutical Design|November 20, 2015
Human Ghrelin: A Gastric Hormone with Cardiovascular PropertiesAgostino Virdis, Lilach O Lerman, Francesco Regoli, et al.
Blood Pressure|June 24, 2008
Skin vasodilator effect of exogenous urotensin-II in hypertensives not exposed to antihypertensive medicationMarco Rossi, Armando Magagna, Cinzia Di Maria, et al.
Pigment Cell & Melanoma Research|June 29, 2018
The relationship between naevus count, memory function and telomere length in the Twins UK cohortStefano Masi, Georgios Georgiopoulos, Simone Ribero, et al.
Obesity Research & Clinical Practice|October 23, 2023
Non-albumin proteinuria marks tubular involvement and is associated with arterial stiffness in subjects affected by severe obesityDiego Moriconi, Monica Nannipieri, Silvia Armenia, et al.
Clinical Drug Investigation|July 3, 2010
Efficacy and safety of olmesartan medoxomil 40 mg/hydrochlorothiazide 12.5 mg combination therapy versus olmesartan medoxomil 40 mg monotherapy in patients with moderate to severe hypertension: a randomized, double-blind, parallel-group, multicentre, multinational, phase III studyRoberto Fogari, Stefano Taddei, Merete Holm-Bentzen, et al.
Journal of Cardiovascular Pharmacology|November 29, 2021
Microvascular Ageing Links Metabolic Disease to Age-Related Disorders: The Role of Oxidative Stress and Inflammation in Promoting Microvascular DysfunctionAlessandro Mengozzi, Nicola Riccardo Pugliese, Martina Chiriacò, et al.
Frontiers in Physiology|August 31, 2012
Sympathetic regulation of vascular function in health and diseaseRosa M Bruno, Lorenzo Ghiadoni, Gino Seravalle, et al.
Journal of Hypertension|February 10, 2025
Impact of kidney function on stiffness of small conduit arteries in hypertension and obesityDiego Moriconi, Monica Nannipieri, Smriti Badhwar, et al.
European Heart Journal|June 1, 2021
Lowering systolic blood pressure to 120 mmHg or The Lancet's true gritFranz H Messerli, Jana Brguljan, Emrush Rexhaj, et al.
Pageof 30

Showing results (101-110 of 291) with videos related to

Sort By:
Pageof 30
Vascular Pharmacology|October 13, 2015
Saxagliptin prevents vascular remodeling and oxidative stress in db/db mice. Role of endothelial nitric oxide synthase uncoupling and cyclooxygenaseAnna Solini, Chiara Rossi, Emiliano Duranti, et al.
Current Pharmaceutical Design|November 20, 2015
Human Ghrelin: A Gastric Hormone with Cardiovascular PropertiesAgostino Virdis, Lilach O Lerman, Francesco Regoli, et al.
Blood Pressure|June 24, 2008
Skin vasodilator effect of exogenous urotensin-II in hypertensives not exposed to antihypertensive medicationMarco Rossi, Armando Magagna, Cinzia Di Maria, et al.
Pigment Cell & Melanoma Research|June 29, 2018
The relationship between naevus count, memory function and telomere length in the Twins UK cohortStefano Masi, Georgios Georgiopoulos, Simone Ribero, et al.
Obesity Research & Clinical Practice|October 23, 2023
Non-albumin proteinuria marks tubular involvement and is associated with arterial stiffness in subjects affected by severe obesityDiego Moriconi, Monica Nannipieri, Silvia Armenia, et al.
Clinical Drug Investigation|July 3, 2010
Efficacy and safety of olmesartan medoxomil 40 mg/hydrochlorothiazide 12.5 mg combination therapy versus olmesartan medoxomil 40 mg monotherapy in patients with moderate to severe hypertension: a randomized, double-blind, parallel-group, multicentre, multinational, phase III studyRoberto Fogari, Stefano Taddei, Merete Holm-Bentzen, et al.
Journal of Cardiovascular Pharmacology|November 29, 2021
Microvascular Ageing Links Metabolic Disease to Age-Related Disorders: The Role of Oxidative Stress and Inflammation in Promoting Microvascular DysfunctionAlessandro Mengozzi, Nicola Riccardo Pugliese, Martina Chiriacò, et al.
Frontiers in Physiology|August 31, 2012
Sympathetic regulation of vascular function in health and diseaseRosa M Bruno, Lorenzo Ghiadoni, Gino Seravalle, et al.
Journal of Hypertension|February 10, 2025
Impact of kidney function on stiffness of small conduit arteries in hypertension and obesityDiego Moriconi, Monica Nannipieri, Smriti Badhwar, et al.
European Heart Journal|June 1, 2021
Lowering systolic blood pressure to 120 mmHg or The Lancet's true gritFranz H Messerli, Jana Brguljan, Emrush Rexhaj, et al.
Pageof 30